BridgeMD
New treatment option for Acute Respiratory Distress Syndrome
Official title Macrophage Programing in Acute Lung Injury: MiniBAL
ClinicalTrials.gov ID: NCT05767671
What this study is testing
- What it's testing
- The goal of this observational clinical trial is to learn about the role white blood cells (macrophages) play in lung inflammation in people with Acute Respiratory Distress Syndrome (ARDS). The main questions it aims to answer are: 1.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Written informed consent (by LAR if subject unconscious or has altered mental status) prior to any study procedures. Verbal consent may be used as...
- Adults greater than 18 years of age
- Admission to the intensive care unit.
- Orally/nasally intubated or expected to be intubated within 48 hours
You likely can't join if
- History of solid organ or bone marrow transplantation
- Severe or massive hemoptysis
- At significant risk for bleeding (INR \> 3 or PTT \> 3x normal)
- Presence of pneumomediastinum or pneumothorax on recent imaging
- Presence of an advanced directive with Do Not Intubate (DNI) status (Do Not Resuscitate (DNR) is acceptable)
- Morbid state or expected to survive less than 24 hours because of an advanced co-morbid medical condition in the opinion of the PI and/or clinical...
See the full eligibility criteria
- Written informed consent (by LAR if subject unconscious or has altered mental status) prior to any study procedures. Verbal consent may be used as necessary
- Adults greater than 18 years of age
- Admission to the intensive care unit.
- Orally/nasally intubated or expected to be intubated within 48 hours
- History of solid organ or bone marrow transplantation
- Severe or massive hemoptysis
- At significant risk for bleeding (INR \> 3 or PTT \> 3x normal)
- Presence of pneumomediastinum or pneumothorax on recent imaging
- Presence of an advanced directive with Do Not Intubate (DNI) status (Do Not Resuscitate (DNR) is acceptable)
- Morbid state or expected to survive less than 24 hours because of an advanced co-morbid medical condition in the opinion of the PI and/or clinical team and attending physician.
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Denver, Colorado, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Denver, Colorado, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.